• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    UNIVERSAL HEALTH REALTY INCOME TRUST ANNOUNCES DIVIDEND INCREASE

    11/25/24 4:30:00 PM ET
    $UHT
    Real Estate Investment Trusts
    Real Estate
    Get the next $UHT alert in real time by email

    KING OF PRUSSIA, Pa., Nov. 25, 2024 /PRNewswire/ -- Universal Health Realty Income Trust (NYSE: UHT) announced today that its Board of Trustees voted to increase the quarterly dividend by $.005 and pay a dividend of $.735 per share on December 31, 2024 to shareholders of record as of December 16, 2024.

    Universal Health Realty Income Trust, a real estate investment trust, invests in healthcare and human service-related facilities including acute care hospitals, behavioral healthcare facilities, rehabilitation hospitals, sub-acute care facilities, surgery centers, childcare centers, and medical office buildings. The Trust has seventy-seven investments in twenty-one states.

    Cision View original content:https://www.prnewswire.com/news-releases/universal-health-realty-income-trust-announces-dividend-increase-302315702.html

    SOURCE Universal Health Realty Income Trust

    Get the next $UHT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $UHT

    DatePrice TargetRatingAnalyst
    More analyst ratings